BRETHAIRE Drug Patent Profile
✉ Email this page to a colleague
When do Brethaire patents expire, and when can generic versions of Brethaire launch?
Brethaire is a drug marketed by Novartis and is included in one NDA.
The generic ingredient in BRETHAIRE is terbutaline sulfate. There are seven drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the terbutaline sulfate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Brethaire
A generic version of BRETHAIRE was approved as terbutaline sulfate by IMPAX LABS on June 26th, 2001.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for BRETHAIRE?
- What are the global sales for BRETHAIRE?
- What is Average Wholesale Price for BRETHAIRE?
Summary for BRETHAIRE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 58 |
Clinical Trials: | 1 |
Patent Applications: | 3,995 |
DailyMed Link: | BRETHAIRE at DailyMed |
Recent Clinical Trials for BRETHAIRE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Yaakov Beilin | Phase 2/Phase 3 |
US Patents and Regulatory Information for BRETHAIRE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Novartis | BRETHAIRE | terbutaline sulfate | AEROSOL, METERED;INHALATION | 018762-001 | Aug 17, 1984 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for BRETHAIRE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Novartis | BRETHAIRE | terbutaline sulfate | AEROSOL, METERED;INHALATION | 018762-001 | Aug 17, 1984 | ⤷ Sign Up | ⤷ Sign Up |
Novartis | BRETHAIRE | terbutaline sulfate | AEROSOL, METERED;INHALATION | 018762-001 | Aug 17, 1984 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for BRETHAIRE
See the table below for patents covering BRETHAIRE around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Germany | 1643296 | ⤷ Sign Up | |
Norway | 132866 | ⤷ Sign Up | |
Norway | 124723 | ⤷ Sign Up | |
Switzerland | 512428 | Verfahren zur Herstellung von neuen 1-(3',5'-Dihydroxy- bzw. -acyloxy-phenyl)-2-aminoäthanolen und deren physiologisch verträglichen Säureadditionssalzen | ⤷ Sign Up |
Switzerland | 510625 | Verfahren zur Herstellung von neuen 1-(3',5'-Dihydroxy- bzw. -acyloxy-phenyl)-2-aminoäthanolen und deren physiologisch verträglichen Säureadditionssalzen (1-3 5-dihydroxyphenyl-2-alkylaminoethanols) | ⤷ Sign Up |
>Country | >Patent Number | >Title | >Estimated Expiration |